Efficacy of lamivudine in patients with hematologic malignancies receiving chemotherapy and precore mutant chronic active hepatitis B

Acta Haematologica

Volumn 107, Issue 1, 2002, Pages 49-51

  Mimidis, Kostantinos ^a   Tsatalas, Costas ^a,b   Margaritis, Dimitris ^a   Martinis, George ^a   Spanoudakis, Emanuel ^a   Kotsiou, Stamatia ^a   Kartalis, George ^a   Bourikas, George ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Regional Hospital of Alexandroupolis   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; LAMIVUDINE; MITOXANTRONE; PREDNISONE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC ACTIVE HEPATITIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE MUTATION; HEMATOLOGIC DISEASE; HEPATITIS B; HUMAN; LIVER INJURY; LYMPHATIC LEUKEMIA; MALE; MUTANT; PRIORITY JOURNAL; VIRUS HEPATITIS; VIRUS REPLICATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DNA, VIRAL; FALSE NEGATIVE REACTIONS; FEMALE; HEMATOLOGIC NEOPLASMS; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; THERAPEUTIC EQUIVALENCY;

EID: 0036288422     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046631     Document Type: Article

References (12)

1. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients
2. Identification of HBV variants which cannot produce pre-core derived HbeAg and may be responsible for severe hepatitis
3. Mutation preventing formation of e antigen in patients with chronic HBV infection
4. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients
5. Hepatitis B infection in patients with lymphoma
6. A preliminary trial of lamivudine for chronic hepatitis B infection
7. Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation
8. An open comparative study of lamivudine and famciclovir in the treatment of chronic hepatitis B
9. A one-year trial of lamivudine for chronic hepatitis B
10. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
11. Lamivudine resistance in immunocompetent chronic hepatitis B: Incidence and patterns
12. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation